[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$allr

$ALLR receives FDA Fast Track designation for Stenoparib, sparking significant interest. Analysts predict substantial upside potential, with the stock showing early gains in pre-market trading.

About $allr

Allarity Therapeutics, Inc. (ALLR) is a biotechnology company focused on developing cancer treatments.

Engagements: XXXXX #

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXX -XX%
1-Year High: XXXXXXX on 2025-08-26
1-Year Low: XXX on 2025-10-05

Social Network	X	YouTube
Engagements	XXXXX	X

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XX -XX%
1-Year High: XXX on 2025-08-27
1-Year Low: XX on 2025-10-12

Social Network	X	YouTube
Mentions	XX	X

Creators: XX #

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $allr in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
1 Month: XX -XX%
1-Year High: XXX on 2025-08-27
1-Year Low: X on 2025-10-12

The most influential creators that mention $allr in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@JS_stockwatch	X	XXXXX	X	XXX
@WTec78	X	XXX	X	XX
@CuLKN42	X	XXX	X	XX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +24%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-09-14

Most Supportive Themes

FDA Fast Track Designation & Clinical Progress: (40%) Positive sentiment around Allarity Therapeutics ($ALLR) receiving FDA Fast Track designation for Stenoparib in advanced ovarian cancer, with mentions of clinical progress and patent expansion.
Potential for Significant Upside: (30%) Bullish sentiment suggesting $ALLR has the potential for significant gains, with some analysts predicting substantial price increases and highlighting the company's technology.
Positive Financial Outlook: (15%) Mentions of positive financial aspects, such as management buybacks, consistent property income, and strategic business alternatives.

Most Critical Themes

Fragile Structure and Pressure: (15%) Some posts indicate that the stock is under pressure, with a fragile structure, and the need for volume reversal or clear signals to validate a bounce.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXX	XX%	XXXXX	XX%	XX	X%
YouTube	X	X%	X	X%	X	X%

Total	XXX	XX%	XXXXX	XX%	XX	X%

Top assets mentioned In the posts about $allr in the last XX hours

SPDR S&P XXX ETF Trust (SPY) Johnson & Johnson (JNJ) Johnson & Johnson (JNJ) Protagonist Therapeutics, Inc (PTGX) Dun & Bradstreet Holdings, Inc. (DNB) Velo (VELO) Velodrome Finance (VELO) Open Custody Protocol (OPEN) MobileCoin (MOB) MOBCAT (MOB)

Top topics mentioned In the posts about $allr in the last XX hours